Literature DB >> 12744547

Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation.

Shaji Kumar1, Laurie D DeLeve, Patrick S Kamath, Ayalew Tefferi.   

Abstract

Hepatic veno-occlusive disease (VOD), increasingly referred to as sinusoidal obstruction syndrome, is a well-recognized complication of hematopoietic stem cell transplantation and contributes to considerable morbidity and mortality. In the Western Hemisphere, VOD, classified as a conditioning-related toxicity, is most commonly caused by stem cell transplantation. VOD has been described after all types of stem cell transplantation, irrespective of the stem cell source, type of conditioning therapy, or underlying disease. Recognition of this disease in the posttransplantation setting remains a challenge in the absence of specific diagnostic features because many other more common conditions can mimic it. Limited therapeutic or preventive strategies are currently available for the management of VOD. In this review, we provide a comprehensive account of the pathophysiology of this disease as we understand it today, risk factors for its development, and the current state of knowledge regarding preventive and therapeutic options.

Entities:  

Mesh:

Year:  2003        PMID: 12744547     DOI: 10.4065/78.5.589

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  35 in total

1.  Earlier defibrotide initiation post-diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome improves Day +100 survival following haematopoietic stem cell transplantation.

Authors:  Paul G Richardson; Angela R Smith; Brandon M Triplett; Nancy A Kernan; Stephan A Grupp; Joseph H Antin; Leslie Lehmann; Maja Miloslavsky; Robin Hume; Alison L Hannah; Bijan Nejadnik; Robert J Soiffer
Journal:  Br J Haematol       Date:  2017-04-26       Impact factor: 6.998

2.  Contribution of ADAMTS13 to the better cell engraftment efficacy in mouse model of bone marrow transplantation.

Authors:  Hideto Matsui; Maiko Takeda; Kenji Soejima; Yasunori Matsunari; Shogo Kasuda; Shiro Ono; Kenji Nishio; Midori Shima; Fumiaki Banno; Toshiyuki Miyata; Mitsuhiko Sugimoto
Journal:  Haematologica       Date:  2014-06-27       Impact factor: 9.941

3.  Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: a retrospective study from the Acute Leukemia Working Party of the EBMT.

Authors:  G Battipaglia; M Labopin; A Candoni; R Fanin; J El Cheikh; D Blaise; M Michallet; A Ruggeri; N Contentin; J M Ribera; M Stadler; J Sierra; P A von dem Borne; A Bloor; G Socié; A Nagler; M Mohty
Journal:  Bone Marrow Transplant       Date:  2017-01-16       Impact factor: 5.483

4.  A phase 1 trial of 90Y-Zevalin radioimmunotherapy with autologous stem cell transplant for multiple myeloma.

Authors:  A Dispenzieri; A D'Souza; M A Gertz; K Laumann; G Wiseman; M Q Lacy; B LaPlant; F Buadi; S R Hayman; S K Kumar; D Dingli; W J Hogan; S M Ansell; D A Gastineau; D J Inwards; I N Micallef; L F Porrata; P B Johnston; M R Litzow; T E Witzig
Journal:  Bone Marrow Transplant       Date:  2017-09-04       Impact factor: 5.483

5.  Standard pentostatin dose reductions in renal insufficiency are not adequate: selected patients with steroid-refractory acute graft-versus-host disease.

Authors:  Ming J Poi; Craig C Hofmeister; Jeffrey S Johnston; Ryan B Edwards; Buffy S Jansak; David M Lucas; Sherif S Farag; James T Dalton; Steven M Devine; Michael R Grever; Mitch A Phelps
Journal:  Clin Pharmacokinet       Date:  2013-08       Impact factor: 6.447

Review 6.  Current approach to early gastrointestinal and liver complications of hematopoietic stem cell transplantation.

Authors:  Erden Atilla; Pınar Ataca Atilla; Güldane Cengiz Seval; Mehmet Bektaş; Taner Demirer
Journal:  Turk J Gastroenterol       Date:  2019-02       Impact factor: 1.852

7.  Inferior vena cava stenosis-induced sinusoidal obstructive syndrome after living donor liver transplantation.

Authors:  Batsaikhan Bat-Erdene; Sergelen Orgoi; Erdene Sandag; Ulzii-Orshikh Namkhai; Bat-Ireedui Badarch; Batsaikhan Batsuuri
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2016-08-29

8.  Iron overload in patients undergoing hematopoietic stem cell transplantation.

Authors:  Vinod Pullarkat
Journal:  Adv Hematol       Date:  2010-09-08

9.  Veno-occlusive disease following high dose melphalan.

Authors:  Tuphan Kanti Dolai; K S Nataraj; Maitreyee Bhattacharya; Malay Kumar Ghosh
Journal:  Indian J Hematol Blood Transfus       Date:  2011-08-18       Impact factor: 0.900

Review 10.  Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome.

Authors:  Jason A Coppell; Paul G Richardson; Robert Soiffer; Paul L Martin; Nancy A Kernan; Allen Chen; Eva Guinan; Georgia Vogelsang; Amrita Krishnan; Sergio Giralt; Carolyn Revta; Nicole A Carreau; Massimo Iacobelli; Enric Carreras; Tapani Ruutu; Tiziano Barbui; Joseph H Antin; Dietger Niederwieser
Journal:  Biol Blood Marrow Transplant       Date:  2009-09-18       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.